Company Profile
MeiraGTx Stock Price, News & Analysis
- Ticker:
- MGTX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United Kingdom with U
Stock performance
12.79 USD (+1.91%)
Close
Last updated: August 6, 2026
856M USD
Market cap
Why the stock is moving
The latest monitored company update is “MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).” The corresponding closing-price reaction is not yet available.
Company overview
Business overview
MeiraGTx is a gene-therapy company focused on ophthalmology, rare disease, and genetics-based medicines. Its platform aims to deliver durable therapies to difficult-to-treat diseases.
Geographic Base and Sector Classification
Headquartered in the United Kingdom with U.S. market exposure and listed on NASDAQ as an ADR, MeiraGTx has a global gene-therapy profile.
Business Model Characteristics
The company depends on clinical development, manufacturing, and strategic partnerships across gene-therapy programs.
Position Within the Biotechnology Landscape
MeiraGTx is a high-catalyst gene-therapy name whose stock is tied to platform and clinical progress.
Future catalysts
MeiraGTx's catalyst setup now looks most tied to its latest development priorities. What gives this more shape is Received FDA Breakthrough Therapy Designation for AAV2-hAQP1 Reported positive three-year data from the Phase 1 AQUAx study of AAV2-hAQP1 for the treatment of grade 2/3 late.... That setup makes the next update more important than the headline financials themselves.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of MeiraGTx (MGTX)?
MeiraGTx (MGTX) most recently closed at 12.79 USD, a +1.91% move versus the previous session.
What is the market cap of MeiraGTx (MGTX)?
MeiraGTx currently has a market capitalization of 856M USD on BioPharmSignal.
What does MeiraGTx do?
MeiraGTx is a gene-therapy company focused on ophthalmology, rare disease, and genetics-based medicines. Its platform aims to deliver durable therapies to difficult-to-treat diseases.
On which exchange is MGTX stock listed?
MeiraGTx (MGTX) is associated with NASDAQ, United Kingdom with U, Biopharma.
What is MeiraGTx?
MeiraGTx's catalyst setup now looks most tied to its latest development priorities.
Which conditions is MeiraGTx targeting with MeiraGTx?
MeiraGTx is associated with rare disease, ophthalmology, genetic disease based on its company overview and current catalyst commentary.
How does MeiraGTx describe recent progress with MeiraGTx?
MeiraGTx's catalyst setup now looks most tied to its latest development priorities.
What is What?
What gives this more shape is Received FDA Breakthrough Therapy Designation for AAV2-hAQP1 Reported positive three-year data from the Phase 1 AQUAx study of AAV2-hAQP1 for the treatment of grade 2/3 late....